
According to Validea's guru fundamental report, Accenture PLC (ACN) receives an 86% rating based on their Patient Investor model, which is based on the investment strategy of Warren Buffett. The rating indicates strong interest in the stock due to the firm’s long-term, predictable profitability, low debt, and reasonable valuation. The report highlights that ACN passes all of the strategy's key tests, including earnings predictability, debt service, return on equity, and free cash flow.
Accenture PLC (ACN) has received a favorable assessment from Validea's guru fundamental report, scoring 86% based on the 'Patient Investor' model, which emulates Warren Buffett's investment principles. This score, indicating notable interest from the strategy (with scores above 80% signifying interest and above 90% strong interest), positions ACN, a large-cap growth stock in the Computer Services industry, positively. The high rating is attributed to ACN's alignment with the strategy's core requirements for firms with long-term, predictable profitability, low debt, and reasonable valuations. Significantly, ACN passed all nine of the model's fundamental tests: Earnings Predictability, Debt Service, Return on Equity, Return on Total Capital, Free Cash Flow, Use of Retained Earnings, Share Repurchase, Initial Rate of Return, and Expected Return, which collectively underscore a robust financial profile according to this specific investment methodology. The sentiment surrounding ACN is strongly positive (0.85 ticker sentiment), reinforcing the fundamental strength highlighted by the Validea report.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment